PATENT CLAIM ANALYSIS

Application Number: 15976584
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "021910"]

Abstract:
The present invention regards specific IBAT inhibitors useful in the prophylaxis and/or treatment of a liver disease. It also relates to compositions comprising these IBAT inhibitors, a method for treatment of the disorders and a kit comprising the substances or the compositions.

Claim (Index 6):
The method according to  claim 2 , wherein the subject has hepatic cirrhosis caused by the non-alcoholic fatty liver disease (NAFLD).

Metadata:
- Claim Count in Document: 15.0
- Percentile: 93.0
- Lexical Diversity: 1.36364
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15726203', '15726071', '15722110', '15276446', '15894472']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7310458112433086
- 35 USC 102 Novelty (BERT): 0.4963659719265259
- Combined Prediction Score: 0.7075778273116303
- Mean Citation Score: 211.27412400000003
- Max Citation Score: 223.22742
- Similarity Product: 165.97724939794062

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test